Page last updated: 2024-11-10

rp 40749

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

RP 40749: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3034005
CHEMBL ID100424
SCHEMBL ID389796
MeSH IDM0106280

Synonyms (29)

Synonym
CHEMBL100424
picartamide
rp-40749
rp 40749
n-methyl-2-pyridin-2-ylthiolane-2-carbothioamide
picartamida [spanish]
unii-7jz930h2m6
einecs 278-531-4
picartamide [inn]
7jz930h2m6 ,
picartamidum [latin]
(+-)-tetrahydro-n-methyl-2-(2-pyridyl)thio-2-thiophenecarboxamide
2-thiophenecarbothioamide, tetrahydro-n-methyl-2-(2-pyridinyl)-
picartamidum
picartamida
n-methyl-2-(2-pyridyl)-2,3,4,5-tetrahydro-2-thiophene carbothioamide
40749 rp
76732-75-7
2-methylaminocarbothioyl-2-(pyridyl)-2-tetrahydrothiophene
(+/-)-tetrahydro-n-methyl-2-(2-pyridyl)thio-2-thiophenecarboxamide
picartamide [mart.]
n-methyl-2-(pyrid-2-yl)tetrahydrothiophene-2-carbothioamide
ITNLONMDUMHEOK-UHFFFAOYSA-N
SCHEMBL389796
Z1509546298
Q27268425
n-methyl-2-(pyridin-2-yl)thiolane-2-carbothioamide
DTXSID30868413
EN300-255609

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The purpose of this work was to compare the effects of a long acting antisecretory drug on 24-h gastric acidity after acute and chronic administration and to correlate the results observed with modifications of pharmacokinetic parameters."( Acute and chronic 24-hour gastric pH and pharmacokinetic studies with a long acting antisecretory drug (40749 RP) in peptic ulcer.
Bonfils, S; Denis, P; Frydman, A; Galmiche, JP; Garcia del Risco, F; Mignon, M; Piat, M; Teule, M, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID178849Antisecretory activity against histamine stimulated gastric acid secretion in Shay rats expressed as ED50 value ranges from (0.1-1.3)1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Synthesis and antisecretory and antiulcer activities of derivatives and analogues of 2-(2-pyridyl)tetrahydrothiophene-2-carbothioamide.
AID188523Antiulcer activity by protection of restraint-induced gastric erosions in rats, by using the technique of Rossi was determined at peroral dose of 4.5 mg/kg1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Synthesis and antisecretory and antiulcer activities of derivatives and analogues of 2-(2-pyridyl)tetrahydrothiophene-2-carbothioamide.
AID176292Antiulcer activity against histamine stimulated gastric acid secretion in Shay rats expressed as ED501987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Synthesis and antisecretory and antiulcer activities of derivatives and analogues of 2-(2-pyridyl)tetrahydrothiophene-2-carbothioamide.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.36 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]